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Abstract

Objective: There have been recent efforts toward creating a health contribution score (HCS) from the Godin
Leisure-Time Exercise Questionnaire (GLTEQ) that reflects public-health guidelines for levels of moderate-tovigorous physical activity (MVPA). The HCS yields categories of insufficiently active (less substantial or low

benefits), moderately active (some benefits), and active (substantial benefits). The present study examined the
validity of the GLTEQ HCS and its categories as reflecting levels of MVPA in multiple sclerosis (MS). Method: The
sample included 684 persons with MS. Participants wore an accelerometer on an elastic belt around the waist
above the nondominant hip during the waking hours of the day over a 7-day period and completed the GLTEQ.
Results: The data analyses supported a large correlation between the GLTEQ HCS and accelerometer-measured
MVPA, r = .46, p < .0001, but small correlations with accelerometer-measured light physical activity (LPA), r =
.16, p < .001 and sedentary time, r = −.13, p = .001. There further was a large difference in accelerometermeasured MVPA between categories of physical activity levels (i.e., insufficiently active vs. active) based on the
GLTEQ HCS (d = 0.89), but small differences in LPA (d = 0.39) and sedentary time (d = −0.31). Those results were
unchanged in additional data analyses accounting for LPA and sedentary behavior. Conclusions: The GLTEQ HCS
and categories primarily reflect MVPA rather than LPA and sedentary behavior in persons with MS. (PsycINFO
Database Record (c) 2018 APA, all rights reserved)

Impact Statement

Impact and Implications—We validated the health contribution score from the Godin Leisure-Time Exercise
Questionnaire as reflecting public-health guidelines for levels of moderate-to-vigorous physical activity in
persons with multiple sclerosis. This is important for describing samples and/or categorizing mean scores and
changes over time with an intervention. This is relevant for identifying patients who might require exercise
promotion and/or rehabilitation programs for targeting comorbid conditions

Introduction
There is increasing interest by researchers and clinicians in understanding and promoting physical activity
behavior among persons with MS (Lai, Young, Bickel, Motl, & Rimmer, 2017; Motl, Learmonth, Pilutti,
Gappmaier, & Coote, 2015). The existing research supports that engaging in physical activity has substantial
benefit for persons with MS (Motl & Sandroff, 2015), and the benefits may be even larger when meeting public
health guidelines for physical activity behavior (Adamson, Ensari, & Motl, 2015). Public health guidelines for
physical activity reflect the amount of MVPA necessary for reducing the risks of morbidity and mortality as well
as optimizing the likelihood of experiencing cardiorespiratory, musculoskeletal, and neuromotor benefits of this
behavior (Garber et al., 2011). The existence of public health guidelines, in part, provide an MVPA benchmark
for health care providers and policymakers when making recommendations on health promoting physical
activity levels among adults 18–64 years of age, including adults with disabilities such as MS.
The increasing interest by researchers and clinicians in understanding and promoting physical activity behavior
among persons with MS requires measures with scores that yield valid and reliable inferences (i.e., score
meaning). The measures should further provide scores that can be easily interpreted and translatable within the
context of public health guidelines for physical activity. This latter quality of a measure is important in research
for describing samples and/or categorizing mean scores and changes over time with an intervention. This further
is important in clinical practice for identifying patients who might require promotion and/or rehabilitation
programs for targeting comorbid conditions.
The GLTEQ (Godin & Shephard, 1985) might fulfill the aforementioned qualities for application in MS. The GLTEQ
is one of the most commonly adopted scales for measuring physical activity in MS (Gosney, Scott, Snook, &
Motl, 2007; Kinnett-Hopkins, Adamson, Rougeau, & Motl, 2017), and contains three core items regarding the
frequency of strenuous, moderate, and mild physical activity for bouts of 15 or more minutes during a 7-day
period. The scores are multiplied by weights and summed into an overall score (i.e., leisure-time physical activity
[LTPA] score) that ranges between 0 and 119 metabolic equivalents of task (METs)/minutes of physical activity

per week. There is evidence for the reliability of LTPA scores from the GLTEQ over a 6-month period in persons
with MS (Motl, McAuley, & Klaren, 2014). There is additional evidence for the validity of LTPA scores in MS
based on correlations with other self-report measures of physical activity as well as objective markers of physical
activity from accelerometry (Gosney et al., 2007). We further note that LTPA scores have captured the efficacy
of behavioral interventions for increasing physical activity in MS (Pilutti, Dlugonski, Sandroff, Klaren, & Motl,
2014). However, the LTPA score does not directly reflect public-health guidelines for levels of physical activity
(i.e., Garber et al., 2011) for ease of interpretation among researchers and clinicians.
There have been recent efforts toward creating a HCS from the GLTEQ that reflects public-health guidelines for
levels of physical activity (Amireault & Godin, 2015; Godin, 2011). The HCS is computed using only the sum of
the weighted strenuous and moderate scores from the GLTEQ, and scores reflect categories of insufficiently
active (less than 14 units; less substantial or low benefits), moderately active (14–23 units; some benefits), and
active (24 units or more; substantial benefits). We are unaware of research validating the GLTEQ HCS and its
categories as reflecting levels and differences in MVPA among persons with MS. This is an important precursor
for the application and interpretation of the GLTEQ HCS in clinical research and practice involving persons with
MS.
We are aware of one previous study examining the validity of the GLTEQ HCS for classifying breast cancer
survivors into active and insufficiently active categories (Amireault, Godin, Lacombe, & Sabiston, 2015). That
study included 199 breast cancer survivors who wore an accelerometer on the waist during the waking hours of
the day for seven consecutive days and completed the GLTEQ after the 7-day period. There was a moderate
sized correlation between accelerometer-measured MVPA minutes/week and the GLTEQ HCS (r = .46), and a
large (d = .78) difference between active and insufficiently active HCS groups/categories in accelerometermeasured MVPA minutes/week. Such data support the convergent validity of the HCS score as reflecting MVPA
in a clinical population, but do not provide divergent validity regarding smaller correlations with other measures
of behavior, including LPA and sedentary behavior. This is important for identifying that the HCS score captures
MVPA rather than LPA and sedentary behavior.
The present study validated the GLTEQ HCS and its categories as reflecting levels of MVPA in MS. We first
examined the correlation between HCS and minutes per day of MVPA, LPA, and sedentary behavior measured
by waist-worn accelerometry, and then examined if the categories of physical activity based on the GLTEQ HCS
reflected differences in amounts of MVPA, LPA, and sedentary behavior. We opted for accelerometry as another
“method” of measuring physical activity for construct validity, consistent with the frameworks of Cronbach and
Meehl (1955) and Campbell and Fiske (1959), and note that it provides an objective measure of ambulatory
physical activity with metrics (i.e., cut points) that have been calibrated with indirect calorimetry while walking
in MS (Sandroff, Motl, & Suh, 2012). We hypothesized (a) a large correlation between the HCS and minutes/day
of MVPA (i.e., r ∼ .50), but a small correlation between the HCS and minutes/day of LPA and sedentary behavior
(i.e., r ∼ .10), and (b) large differences in minutes/day of MVPA between categories of physical activity levels
(i.e., insufficiently active vs. active) based on HCS (i.e., d ∼ .80), but small HCS group differences in LPA and
sedentary behavior (i.e., d ∼ .30). If our hypotheses are supported, this study would provide convergent and
divergent evidence for the construct validity of the GLTEQ HCS and its categories in MS.

Method
Sample

Prospective participants were recruited from the Midwestern portion of the United States using multiple
sources, including print and e-mail flyers, an online advertisement on the National Multiple Sclerosis Society
website, and our database of previous participants with MS. The advertisements described a study examining

physical activity behavior in persons with MS. The inclusion criteria were (a) definite physician diagnosis of MS
that was confirmed in writing by the participant’s physician, (b) self-reported relapse-free in the previous 30
days, (c) ambulatory with or without assistive devices, and (d) age between 18 and 64 years. The final sample
included 684 persons with MS who volunteered and completed the study procedures.

Measures
GLTEQ

The GLTEQ measures the frequency of strenuous, moderate, and mild LTPA performed for periods of 15 min or
more over a usual week. Recently, a new scoring method has been proposed for generating an overall GLTEQ
score that aligns with current recommendations for physical activity and the dose—response association
between the volume of physical activity and health benefits (i.e., HCS; Amireault & Godin, 2015; Godin, 2011). The
HCS is based on only strenuous and moderate physical activity and is computed by multiplying the frequencies
of strenuous and moderate activities by 9 and 5 METs, respectively, and then adding the resultant scores. The
HCS ranges between 0 and 98 and is converted into one of three categories, namely, insufficiently active (i.e.,
score <14 units that is the equivalent of <7 kcal/kg/week), moderately active (i.e., score between 14 and 23 units
that is the equivalent of between 7 and 13.9 kcal/kg/week), and active (i.e., score ≥24 units that exceeds 13.9
kcal/kg/week).

Accelerometry

The study included a pool of 100 ActiGraph Model 7164 accelerometers, as this model and its location of
placement (i.e., waist) has been validated for capturing intra- and interperson variation in ambulatory physical
activity in MS (Motl, Sosnoff, Dlugonski, Suh, & Goldman, 2010). This model of accelerometer measures physical
activity as activity counts per unit time using a piezoelectric bender element that produces an electrical signal
proportionate to the force acting on it during movement. The electric signal is digitally converted into activity
counts amalgamated over 1-min sampling intervals (i.e., 60-s epochs), and the activity counts per minute are
stored in the accelerometer’s random access memory. Of note, all 100 accelerometers were calibrated prior to
data collection for accurately measuring physical activity by laboratory staff members who walked on a treadmill
(4.8 km/h, 0% grade for 15 min) while wearing the accelerometers on a belt around the waist. Accuracy was
confirmed by a <10% difference in average counts per minute across the 15-min period of walking among the
accelerometers worn simultaneously. The data from the accelerometers were downloaded and processed using
ActiLife software. The data were then processed into two separate Microsoft Excel files representing wear time
and time spent in sedentary behavior, LPA, and MVPA; this later processing was based on activity count cut
points for persons with MS (i.e., sedentary: 0–99 counts/minute; LPA: 100–1,722 counts/minute; MVPA: ≥1,723
counts/minute; Sandroff, Motl, & Suh, 2012). Those cut points were derived from a direct calibration of
accelerometer output based on its strong association with energy expenditure during walking in a sample of 43
persons with MS who ambulated with or without assistive devices (R2 = 0.91; Sandroff et al., 2012). Accelerometer
wear time data were checked against participant recorded wear times from a log sheet, and only valid days (>10
hr of wear time without periods of continuous zeros exceeding 60 min indicative of noncompliance) were
included in the analyses. All participants had two or more days of valid accelerometer data, regardless of
weekday or weekend day (Motl et al., 2007), and we averaged the available and valid daily data into a metric of
average minutes/day for MVPA, LPA, and sedentary behavior.

Patient Determined Disease Steps (PDDS) Scale

The PDDS provides a patient-reported measure of disability status in MS, and has nine ordinal levels ranging
between 0 (normal) and 8 (bedridden; Hadjimichael, Kerns, Rizzo, Cutter, & Vollmer, 2007). The scores from this
scale have been validated in MS based on correlations with scores from the Expanded Disability Status Scale (r =

.783) as well as measures of ambulation including the 6-min walk (r = –.704), timed 25-foot walk (r = .627), and
Multiple Sclerosis Walking Scale-12 (r = .800; Learmonth, Motl, Sandroff, Pula, & Cadavid, 2013).

Procedures

The procedures were approved by a university institutional review board, and all participants provided informed
consent. Participants were screened over the telephone for inclusion criteria, and those who qualified received
initial instructions on the study procedures, including properly wearing the accelerometer. We then sent
participants a packet through the United States Postal Service containing the accelerometer along with a log
sheet and standardized instructions with pictures, the GLTEQ, Demographic/Clinical Questionnaire, PDDS, and a
prestamped/preaddressed envelope for returning the materials. We further phoned participants for ensuring
understanding with instructions for wearing the accelerometer and completing the GLTEQ. We instructed the
participants to wear the accelerometer around the waist above the nondominant hip using the provided elastic
belt during the waking hours of the day over a 7-day period and recorded wear time in a log sheet. Waking
hours was defined as the time from waking and getting out of bed in the morning until getting into bed for sleep
in the evening. Participants completed the GLTEQ within 24 hr after wearing the accelerometer, and completed
the Demographic/Clinical Characteristic Questionnaire and PDDS for characterizing the sample when
convenient. The materials were returned through the United States Postal Service in a prestamped and
preaddressed envelope. We paid participants $25 for completing the study procedures.

Data Analysis

The data were analyzed in IBM SPSS Version 24.0. We provide descriptive statistics as mean score and standard
deviation (SD), unless otherwise noted. The first primary analysis examined the association between the GLTEQ
HCS and minutes/day of MVPA, LPA, and sedentary behavior from the accelerometer using a Pearson productmoment correlation coefficient (r), and interpreted the magnitude based on guidelines of .1, .3, and .5 as small,
moderate, and large, respectively (Cohen, 1988). The second primary analysis compared minutes/day of MVPA as
well as LPA and sedentary behavior from the accelerometer among the three categories of physical activity
based on the GLTEQ HCS using a one-way analysis of variance (ANOVA) with Bonferroni adjusted post hoc
analyses (p = .0167) per ANOVA (i.e., controlling error rate per analysis), and interpreted the magnitude of group
differences based on guidelines of .3, .5, and .8 as small, moderate, and large, respectively (Cohen, 1988). We
further report partial eta-squared (η2) as an overall effect size estimate per ANOVA with values of .01, .06, and
.12 representing small, medium, and large effects, respectively (Cohen, 1988).

Results
Sample Characteristics

The sample of 684 persons with MS had a mean (SD) age of 47.1 (10.2) years, and consisted of 554 women and
102 men; 28 persons did not report sex. The sample mean (SD) disease duration was 9.8 (7.5) years, and 598 had
relapsing-remitting MS (RRMS) and 71 had progressive MS; 15 persons had an unknown disease course. The
median (interquartile range) PDDS score was 2.0 (3.0) indicating moderate ambulatory disability. There were
176 persons (25.6%) who used an assistive device for ambulation based on the criterion of a PDDS score of 4.0
(i.e., early cane) or greater.

Physical Activity Profile

LPA and sedentary behavior scores approximated a normal distribution, whereas HCS and MVPA scores deviated
from a normal distribution (i.e., positive skewness); this is consistent with the distribution of MVPA in MS and
the general population of adults (i.e., very few persons are currently achieving recommended levels of physical
activity; Kinnett-Hopkins et al., 2017). The distribution of HCS scores is provided in Figure 1, and the skewness and
kurtosis values for the distribution were 1.45 and 1.85, respectively. We included parametric analyses

considering robustness against deviations from normality with such a large sample size (Tabachnik & Fidell, 1996).

Figure 1. Histogram of health composite scores (HCS) from the Godin Leisure Time Exercise Questionnaire in 684 persons
with multiple sclerosis.

The mean (SD) for the GLTEQ HCS was 16.8 (20.6). Based on the GLTEQ HCS, there were 367 (53.7%), 109
(15.9%), and 208 (30.4%) cases of persons with MS in the insufficiently active, moderately active, and active
groups, respectively. The mean (SD) scores for minutes/day of MVPA, LPA, and sedentary time from the
accelerometer were 19.3 (19.6), 290.2 (79.3), and 526.1 (93.0), respectively. The mean (SD) wear time was 835.1
(80.0) minutes/day.

Correlation Between Scores
There was a statistically significant and strong correlation between the GLTEQ HCS and accelerometer-measured
minutes/day of MVPA, r = .46, p < .0001. That correlation was significantly larger in magnitude than the
correlations between the HCS and accelerometer-measured minutes/day of LPA, r = .16, p < .001 and sedentary
behavior, r = −.13, p = .001, based on Fisher’s z test for comparing the different in dependent correlations
(Steiger, 1980). Importantly, the correlation between the GLTEQ HCS and accelerometer-measured minutes/day
of MVPA was virtually unchanged when controlling for LPA and sedentary time in a follow-up partial correlation
analysis (pr = .44, p < .0001).

Comparison of Scores Among Groups
The mean (SD) minutes/day of MVPA, LPA, and sedentary behavior from the accelerometer for the three groups
of insufficiently active, moderately active, and active are provided in Table 1. The ANOVA indicated an overall
large and statistically significant difference among groups (F(2, 681) = 50.8, p < .0001, η2 = .13), and follow-up
comparisons with Bonferroni correction indicated that all three groups differed significantly in minutes/day of
MVPA. The effect sizes for insufficiently active versus moderately active groups and moderately active versus
active groups were 0.34 and 0.51, respectively. The effect size for insufficiently active versus active groups was
0.89.

Table 1 Descriptive Statistics for Physical Activity and Sedentary Outcomes From the Accelerometer Across Groups of
Physical Activity Based on the Health Composite Score From the Godin Leisure Time Exercise Questionnaire

Accelerometer variable
MVPA (minutes/day)
LPA (minutes/day)
Sedentary (minutes/day)

Health composite score
group
Insufficiently active
13.6 (14.5)
280.3 (78.4)
534.0 (93.4)

Moderately active
18.7 (16.1)
285.6 (82.8)
538.3 (95.8)

Active
29.6 (24.3)
310.1 (75.6)
505.6 (87.8)

The ANOVA indicated an overall small, but statistically significant, difference among groups (F(2, 681) = 9.9, p <
.0001,η2 = .03), and follow-up comparisons with Bonferroni correction indicated that the inactive and
insufficiently active groups both differed significantly from the active group in minutes/day of LPA. The effect
sizes for insufficiently active versus moderately active groups and moderately active versus active groups were
0.07 and 0.31, respectively. The effect size for insufficiently active versus active groups was 0.39.
The ANOVA indicated an overall small, but statistically significant, difference among groups (F(2, 681) = 7.5, p <
.001, η2 = .02), and follow-up comparisons with Bonferroni correction indicated that the inactive and
insufficiently active groups both differed significantly from the active group in minutes/day of sedentary
behavior. The effect sizes for insufficiently active versus moderately active groups and moderately active versus
active groups were 0.04 and −0.36, respectively. The effect size for insufficiently active versus active groups was
−0.31.

Independence of Group Differences in MVPA

We conducted an analysis of covariance (ANCOVA) for comparing groups on accelerometer-measured
minutes/day of MVPA controlling for LPA and sedentary time, and there was an overall moderate-to-large and
statistically significant difference among groups (F(2, 679) = 42.8, p < .0001, η2 = .09). The follow-up comparisons
with Bonferroni correction indicated that all three groups based on the GLTEQ HCS differed significantly in
accelerometer-measured minutes/day of MVPA. The adjusted mean minutes/day of MVPA from the
accelerometer were 14.0, 19.2, and 28.6 for insufficiently active, moderately active, and active groups,
respectively.

Discussion
This study examined the validity of the GLTEQ HCS and its categories (Amireault & Godin, 2015; Godin, 2011) as a
measure of MVPA in persons with MS. The notable results, as expected, supported (a) a large correlation
between the GLTEQ HCS and accelerometer-measured MVPA, but small correlations between the GLTEQ HCS
and accelerometer-measured LPA and sedentary behavior; (b) a large difference in accelerometer-measured

MVPA between categories of physical activity levels (i.e., insufficiently active vs. active) based on the GLTEQ
HCS, but small differences in LPA and sedentary behavior; and (c) independence of both the correlation between
the HCS and accelerometer-measured MVPA and the difference in accelerometer-measured MVPA across HCS
categories when accounting for LPA and sedentary behavior. This pattern of results suggests that the GLTEQ HCS
and categories primarily reflect MVPA (i.e., convergent validity) rather than LPA and sedentary behavior (i.e.,
divergent validity) in persons with MS. These results may have significant value for researchers and clinicians
who are interested in understanding and promoting physical activity behavior among persons with MS. We have
provided evidence that the GLTEQ HCS can be interpreted regarding public health guidelines for physical
activity. This is important as researchers can adopt the GLTEQ HCS for describing samples and/or categorizing
mean scores and changes over time with an intervention. We further believe that there is relevance for clinical
practice wherein health care providers can apply the GLTEQ HCS for identifying patients who might require
physical activity promotion and/or rehabilitation programs for targeting comorbid conditions. This is important,
given that the existence of public health guidelines, in part, provide a basis for health care providers and
policymakers when making recommendations on health-promoting physical activity levels among adults 18–64
years of age, including adults with disabilities such as MS.
Our results are consistent with previous research examining the validity of the GLTEQ HCS using accelerometry
in a sample of 199 breast cancer survivors (Amireault et al., 2015). That study reported a similar sized correlation
(r = .46) between accelerometer-measured MVPA minutes/week and the GLTEQ HCS, and a large (d = .78)
difference between active and insufficient active groups/categories in MVPA minutes/week. One important
distinction between studies is that our analyses controlled for LPA and sedentary behavior, and reported
independence of the association between HCS and minutes/day of MVPA. Collectively, these results confirm
that the GLTEQ HCS can be interpreted as reflecting MVPA in breast cancer survivors and persons with MS, and
our results further strengthen this inference as unique for MVPA rather than LPA and sedentary behavior based
on additional partial correlation and ANCOVA analyses in a large sample of persons with MS. This latter point is
important, as the HCS score only includes moderate and strenuous physical activity and excludes LPA.
We envision several next steps as well as implications for future research and practice based on the results of
this study. Regarding next steps, researchers might consider examining the usefulness of the GLTEQ HCS for
predicting short- and long-term health outcomes such as depression, fatigue, pain, and quality of life in MS.
Researchers might further consider examining the usefulness of the GLTEQ HCS as a potential consequence of
disease-related outcomes (i.e., mobility disability). This, in turn, might provide a guideline for prescreening
subjects based on inclusion/exclusion for randomized controlled trials of physical activity behavior change in MS.
We might further examine the utility of the GLTEQ HCS in clinical practice for making recommendations on
health behavior change and/or referrals for counseling on behavior change. The GLTEQ HCS is a relatively simple
scoring algorithm on a straightforward questionnaire that is easily interpretable for both practitioners and
patients within the context of published public health guidelines for accruing benefits associated with MVPA
behavior. As such, the GLTEQ HCS might be particularly advantageous for use in such clinical settings,
considering the specialized equipment, software, and expertise required for objective accelerometry.
There are some limitations of this study. The first limitation is that the accelerometer for validating the HCS was
worn on a belt around the waist, and this captures only ambulatory physical activity. To that end, the
correlations and differences we reported might have been underestimated by missing water-based physical
activity and/or cycling, as examples, although we note that walking is the most common type of physical activity
undertaken in MS (Weikert, Dlugonski, Balantrapu, & Motl, 2011). Another limitation was that we only included
cross-sectional data and analyses, and did not provide evidence for the test–retest reliability of the HCS over
time or changes in the HCS and its categories as reflecting changes in MVPA over time. The last limitation was

that the sample primarily included women with RRMS who were ambulatory, thereby limiting generalizability
among the broader community with MS.
Overall, we provide the first evidence for the validity of inferences from the GLTEQ HCS and its categories as
reflecting MVPA in MS, and this evidence is complementary with that provided in breast cancer survivors
(Amireault et al., 2015). There is room for additional investigation regarding the validity and value of GLTEQ HCS in
MS, but the current evidence is strong enough for recommendations that researchers and clinicians can adopt it
in clinical research and practice involving MS. Such application has obvious value for describing samples and/or
categorizing mean scores and changes over time in clinical research, and identifying patients who might require
promotion and/or rehabilitation programs for targeting comorbid conditions in clinical practice.
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